Stimulatory effects of opioids

British Journal of Anaesthesia

Volumn 81, Issue 1, 1998, Pages 20-28

  Harrison, Charlotte ^a   Lambert, David G ^a   Smart, Darren ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

Author keywords

Metabolism, second messengers; Opioids; Opioids, tolerance; Receptors, opioid

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROTRANSMITTER; NOCICEPTIN; OPIATE; OPIATE RECEPTOR; PHOSPHATIDYLINOSITIDE;

CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG TOLERANCE; ENZYME ACTIVATION; HYDROLYSIS; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 2642645377     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/81.1.20     Document Type: Review

References (102)

1. Allouche S, Polastron J, Jauzac P. The δ-opioid receptor regulates activity of ryanodine receptors in the human neuroblastoma cell line SK-N-BE. Journal of Neurochemistry 1996; 67: 2461-2470.
2. Ammer H, Schulz R. Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in Gsα. Molecular Pharmacology 1997; 52: 995-999.
3. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, Vogel Z. Chronic opioid treatment induces adenylyl cyclase V superactivation. Journal of Biological Chemistry 1996; 271: 21309-21315.
4. Avidor-Reiss T, Nevo I, Saya D, Baywitch M, Vogel Z. Opiate-induced adenylyl cyclase superactivation is isozyme specific. Journal of Biological Chemistry 1997; 272: 5040-5477.
5. 3H] thymidine incorporation into DNA: evidence for the involvement of a pertussis-toxin sensitive G protein-coupled phosphoinositide turnover. Journal of Neurochemistry 1993; 60: 1505-1511.
6. Barg J, Nah SY, Levy R, Saya D, Vogel Z. Modulation of thymidine incorporation by kappa opioid ligands in rat spinal chord dorsal root ganglion co-cultures. Brain Research 1993; 629: 109-114.
7. Berridge MJ. A tale of two messengers. Nature 1993; 365: 388-389.
8. Berridge MJ. Elementary and global aspects of calcium signaling. Journal of Physiology 1997; 499: 291-306.
9. Bourgoin S, Benoliel JJ, Collin E, Mauborgne A, Pohl M, Hamon M, Cesselin F. Opioidergic control of the spinal release of neuropeptides - possible significance for the analgesic effects of opioids. Fundamental and Clinical Pharmacology 1994; 8: 307-321.
10. 2+ channels to release adenosine from spinal cord synaptosomes. Journal of Neurochemistry 1993; 60: 894-901.
11. Cahill CM, White TD, Saynok J. Spinal opioid receptors and adenosine release - neurochemical and behavioral characterization of opioid subtypes. Journal of Pharmacology and Experimental Theraputics 1995; 273: 84-93.
12. Capeyrou R, Riond J, Corbani M, Lepage JF, Bertin B, Emorine LJ. Agonist-induced signaling and trafficking of the μ-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C terminal domain. FEBS Letters 1997; 415: 200-205.
13. Chen L, Huang LYM. Sustained potentiation of NMDA receptor mediated glutamate responses through activation of protein-kinase-C by a mu-opioid. Neuron 1991; 319-326
14. Chiara DG, North RA. Pharmacology of opiate abuse. Trends in Pharmacological Sciences 1992; 13: 185-193.
15. Clapham DE. Calcium signaling. Cell 1995; 80: 259-268.
16. Collier HOJ, Francis DL, McDonald-Gibson WJ, Roy AC, Saeed SA. Prostoglandins, cyclic AMP and the mechanism of opiate dependence. Life Sciences 1975; 17: 85-90.
17. Connor M, Henderson G. δ- and μ-opioid mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology 1996; 117: 333-340.
18. Connor MA, Keir MJ, Henderson G. δ-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for δ-receptor subtypes. Neuropharmacology 1997; 36: 125-133.
19. 2+ in the SH-SY5Y human neuroblastoma cell-line. British Journal of Pharmacology 1996; 118: 205-207.
20. Cooper DMF, Mons M, Karpen JW. Adenylyl cyclases and the interaction between calcium and cAMP signaling. Nature 1995; 373: 421-424.
21. Grain SM, Shen KF. Opioids can evoke direct receptor mediated excitatory effects on sensory neurons. Trends in Pharmacological Sciences 1990; 11: 77-81.
22. Grain SM, Shen KF. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Research 1992; 575: 13-24.
23. Grain SM, Shen KF. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance and dependence. Neurochemical Research 1996; 21:1347-1351.
24. Cruciani RA, Dvorkin B, Morris SA, Grain SM, Mackmam MH. Direct coupling of opioid receptors to both stimulatory and inhibitory guanine nucleotide binding proteins in F11 neuroblastoma sensory neuron hybrid cells. Proceedings of the National Academy of Sciences USA 1993; 90: 3019-3013.
25. Cvejic S, Trapaidze N, Cyr C, Devi LA. Thr 353, located within the C-terminal tail of the δ-opiate receptor, is involved in receptor down-regulation. Journal of Biological Chemistry 1996; 271: 4073-4076.
26. Devine DP, Leone P, Pocock D, Wise RA. Differential involvement of ventral tegmental-mu, tegmental-delta and kappa-opioid receptors in modulation of basal mesolimbic dopamine release - in-vivo microdialysis studies. Journal of Pharmacology and Experimental Therapeutics 1993, 266: 1236-1246.
27. Dhawan BN, Celsselin F, Raghubir R, Reisine T, Bradley PB, Ponoghese PS, Hamon M. International Union of Pharmacology: 12. Classification of opioid receptors. Pharmacological Reviews 1996; 48: 567-592.
28. Eriksson PS, Nilson M, Wagberg M, Hanson E, Ronback L. Kappa opioid receptors on astrocytes stimulate L-type calcium channels. Neuroscience 1993; 54: 401-407.
29. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH. Cloning of a delta-opioid receptor by functional expression. Science 1992; 258: 1952-1955.
30. Fields A, Gafni M, Oron Y, Sarne Y. Multiple effect of opiates on intracellular calcium level and on calcium uptake in three neuronal cell lines. Brain Research 1994; 687: 94-102.
31. Fields A, Sarne Y. The stimulatory effect of opioids on cyclic AMP production in SK-N-SH cells is mediated by calcium ions. Life Sciences 1997; 61: 595-602.
32. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. European Journal of Pharmacology 1996; 300: 173-181.
33. 2+ signaling in the brain. Journal of Neurochemistry 1995; 64: 953-960.
34. Gintzler AR, Adapa ID, Toll L, Medima VM, Wang L. Modulation of enkephalin release by nociceptin (orphanin FQ). European Journal of Pharmacology 1997; 325: 29-34.
35. Harrison C, Rowbotham DJ, Devi LA, Lambert DG. Activation of the d-opioid receptor in CHO cells increases intracellular calcium. British Journal of Pharmacology 1997; 120: 222P.
36. Henderson G, McKnight AT. The orphan opioid receptor and its endogenous ligand - nociceptin/orphanin FQ. Trends in Pharmacological Sciences 1997; 18: 293-300.
37. 2+ dependent responses in visceral primary afferent neurons. Brain Research 1982; 251: 186-191.
38. Hirst RA, Hirota K, Grandy DK, Lambert DG. Coupling of the cloned rat κ-opioid receptor to adenylyl cyclase is dependent on receptor expression. Neuroscience Letters 1997; 232: 119-122.
39. Hirst RA, Smart D, Devi LA, Lambert DG. Effects of C-terminal truncation of the recombinant δ-opioid receptor on phospholipase C and adenylyl cyclase coupling. Journal of Neurochemistry 1998; in press.
40. Ingram SL, Williams JT. Opioid inhibition of I-h via adenylyl-cyclase. Neuron 1994; 13: 179-186.
41. Jin W, Lee NM, Loh HH, Thayer SA. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. Journal of Neuroscience 1994; 14: 1920-1929.
42. Johnson PS, Wang JB, Url GR. μ-opioid receptor structure function studies II: effects on second messenger systems. Regulatory Peptides 1995; 54: 139-140.
43. 2+ and stimulation of cyclic AMP production by κ-opioid receptors expressed in Xenopus oocytes. Molecular Brain Research 1994; 27: 258-264.
44. Keren O, Gafni M, Sarne Y. Opioids potentiate neurotransmitter release from SK-N-SH human neuroblastoma cells by modulating N-type calcium channels. Brain Research 1997; 764: 277-282.
45. Kieffer B, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta-opioid receptor: isolation of cDNA by expression cloning and pharmacological characterization. Proceedings of the National Academy of Sciences USA 1992; 89: 12048-12052.
46. Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI. Molecular biology and pharmacology of cloned opioid receptors. FASEB Journal 1995; 9: 516-525.
47. Kovoor A, Henry DJ, Chavkin C. Agonist induced desensitization of the mu-opioid receptor coupled potassium channel (GIRK1). Journal of Biological Chemistry 1995; 270: 589-595.
48. 3H]noradrenaline release from SH-SY5Y cells. Biochemical Pharmacology 1993; 46: 1145-1150.
49. Laurent SD, Marsh JD, Smith TW. Enkephalins increase cyclic adenosine monophosphate content, calcium uptake and contractile state in cultured chick embryo heart neurons. Journal of Clinical Investigation 1986; 77: 1436-1440.
50. 1-13 on cardiac rhythm and cyclic adenosine monophosphate (cAMP) levels in the isolated perfused rat heart. Neuroscience Letters 1987; 80: 289-292.
51. Leslie FM. Methods used for the study of opioid receptors. Pharmacological Reviews 1987; 39: 197-249.
52. Levitan IB. Phosphorylation of ion channels. Journal of Membrane Biology 1985; 87: 77-190.
53. Lin Y, Carpenter DO. Direct excitatory effects mediated by non-synaptic actions on rat medial vestibular neurons. European Journal of Pharmacology 1994; 262 :99-106.
54. Lorentz M, Hedlund B, Arhem P. Morphine activates calcium channels in cloned mouse neuroblastoma cell lines. Brain Research 1988; 445: 157-159.
55. Mackman MH, Dvorkin B, Crain SM. Modulation of adenylate cyclase activity of mouse spinal chord ganglion explants by opioids, serotonin and pertussis toxin. Brain Research 1988; 445: 303-313.
56. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ. Increases in PKC-γ immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Research 1995; 677: 257-267.
57. Mayer DJ, Mao J, Price DD. The development of morphinetolerance and dependence is associated with translocation of protein-kinase-C. Pain 1995; 61: 365-374.
58. Mehta CS, Strada SJ, Effects of acute and continuous administration of morphine on the cyclic AMP response induced by norepinephrine in rat brain slices. Life Sciences 1994; 55: 35-42.
59. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian Y, Liu J, Schulman H, Yu L. The human μ-opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. Journal of Neuroscience 1995; 15: 2396-2406.
60. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL(1) receptor. Nature 1995; 377: 532-535.
61. Miyamae T, Fukushima N, Misu Y, Ueda H. δ-opioid receptor mediates phosphilipase C activation via Gi in Xenopus oocytes. FEBS Letters 1993; 333: 311-314.
62. Mollereau C, Palmentier M, Mailleux P, Boutour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL1, a novel member of the opioid receptor family - cloning, functional expression and localization. FEBS Letters 1994; 341: 33-38.
63. Narita M, Narita N, Mizoguchi H, Tseng LF. Inhibition of protein-kinase-C, but not of protein-kinase-A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. European Journal of Pharmacology 1995; 280: R1-R3.
64. Neer EJ. Heterotrimeric G-proteins - organizers of transmembrane signals. Cell 1995; 80: 249-257.
65. 2+ system through cross-talk between opioid receptors and P2 purinergic or bradykinin receptors in NG108-15 cells. Biochemical Journal 1993; 290: 241-247.
66. Olianas MC, Onali P. Synergistic action of muscarinc and opioid receptors with Gs-linked neurotransmitter receptors to stimulate adenylyl cyclase activity of rat olfactory bulb. Journal of Neurochemistry 1993; 61: 2183-2190.
67. 2+/calmodulin- and forskolin stimulated enzyme activities in rat olfactory bulb. Journal of Neurochemistry 1994; 63: 161-168.
68. Pak Y, O'Dowd BF, George SR. Agonist induced desensitization of the μ-opioid receptor is determined by threonine 394 proceeded by acidic amino acids in the COOH-terminal tail. Journal of Biological Chemistry 1997; 272: 24961-24965.
69. Puri SK, Cochin J, Volicer L. Effects of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum. Life Sciences 1975; 16: 759-768.
70. Reinscheid RK, Northacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ, Civelli O. Orphanin-FQ - a neuropeptide that activates an opioid-like G-protein-coupled receptor. Science 1995; 270: 792-794.
71. Sarne Y, Fields A, Karen O, Gafhi M. Stimulatory effects of opioids on transmitter release and possible cellular mechanisms: overview and original results. Neurochemical Research 1996; 11: 1353-1361.
72. Sarne Y, Gafni M. Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG108-15 neuroblastoma. Brain Research 1996; 722; 203-206.
73. Sarne Y, Gafni M, Fields A, Keren O. Dual effects of opioids on transmitter release, intracellular calcium and calcium-uptake in SK-N-SH cell-line. Regulatory Peptides 1994; 54: 253-254.
74. Sharma SK, Klee WA, Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proceedings of the National Academy of Sciences USA 1975; 72: 3092-3096.
75. Shen KF, Crain SM. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Research 1994; 636: 286-297.
76. Shen KF, Crain SM. Nerve growth factor rapidly prolongs the action potential of mature sensory neurons in culture and this effect requires activation of Gs coupled excitatory kappa receptors on these cells. Journal of Neuroscience 1994; 14: 5570-5579.
77. Shen KF, Crain SM. Specific N-terminus or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists. Brain Research 1995; 673: 30-38.
78. i and adenylyl cyclase. British Journal of Pharmacology 1997; 120: 1165-1171.
79. Smart D, Lambert DG. δ-opioids stimulate of inositol (1,4,5)trisphosphate formation in undifferentiated NG108-15 cells. Analgesia 1995; 1: 746-749.
80. Smart D, Lambert DG. The stimulatory effects of opioids and their possible role in the development of tolerance. Trends in Pharmacological Sciences 1996; 17: 264-269.
81. Smart D, Lambert DG. δ-Opioids stimulate inositol 1,4,5-trisphosphate formation, and so mobilize calcium from intracellular stores, in undifferentiated NG108-15 cells. Journal of Neurochemistry 1996; 66; 1462-1467.
82. Smart D, Smith G, Lambert DG. μ-opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein. Journal of Neurochemistry 1994; 62: 1009-1014.
83. Smart D, Smith G, Lambert DG. μ-opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium channel opening. Biochemical Journal 1995; 305: 577-582.
84. Steine-Martin A, Mattson MP, Hauser KF. Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphological differentiation. Developmental Brain Research 1993; 76: 189-196.
85. Tai KK, Bian CF, Wong TF. κ-opioid receptor stimulation increases intracellular free calcium in isolated rat myocytes. Life Sciences 1992; 51: 909-913.
86. Tang T, Kiang JG, Cox BM. Opioids acting through delta receptors increase the intracellular free calcium concentra- tion in dorsal root ganglion neuroblastoma hybrid ND8-47 cells. Journal of Pharmacology and Experimental Therapeutics 1994; 270: 410-416.
87. Thompson RC, Mansour A, Akil H, Watson SJ. Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron 1993; 903-913.
88. Traber J, Gulliis R, Hamprecht B. Influence of opiates on levels of adenosine 3′5′ cyclic monophosphate in neuroblastoma × glioma hybrid cells. Life Sciences 1975; 16: 1863-1868.
89. Trapaidze N, Keith DE, Cvejic S, Evans CJ, Devi LA. Sequestration of the δ-opioid receptor: role of the C terminus in agonist-mediated internalization. Journal of Biological Chemistry 1996; 271: 29279-29285.
90. Tsu RC, Chan JS, Wong YH. Regulation of multiple effectors by the cloned δ-opioid receptor: Stimulation of phospholipase C and type II adenylyl cyclase. Journal of Neurochemistry 1995; 2700-2707.
91. Ueda H, Miyamae T, Fukushima N, Takeshima H, Fukuda K, Sakasi Y, Misu Y. Opioid mu- and kappa- opioid receptors mediate phospholipase C activation through Gi1 in Xenopus oocytes. Molecular Brain Research 1995; 32: 166-170.
92. Vizi ES, Harsing LG, Knoll J. Presynaptic inhibition leading to dis-inhibition of acetylcholine release from interneurons of the caudate nucleus effect dopamine, β-endorphin and D-ala2-pro5 enkephalinamide. Neuroscience 1977; 2: 953-961.
93. Wandless A, Smart D, Lambert DG. Fentanyl increases intracellular calcium concentration in SH-SH5Y cells. British Journal of Anaesthesia 1996; 76; 461-463.
94. Wang L, Gintzler AR. Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opioid receptors to adenylyl cyclase. Journal of Neurochemistry 1994; 63: 17266-1730.
95. Wang L, Gintzler AR. Morphine tolerance and physical dependence: reversal of opioid inhibition to enhancement of cyclic-AMP formation. Journal of Neurochemistry 1995; 64: 1102-1106.
96. Wang L, Gintzler AR. Altered μ-opiate receptor-G protein signal transduction following chronic morphine exposure. Journal of Neurochemistry 1997; 68: 248-254.
97. Wang L, Medina VM, Rivera M, Gintzler AR. Relevance of phosphorylation state to opioid responsiveness in opioid naive and tolerant/dependent tissue. Brain Research 1996; 723: 61-69.
98. Wick MJ, Minnerath SR, Lin X, Elde R, Law PY, Loh HH. Isolation of a novel cDNA encoding a putative membrane-receptor with high homology to the cloned mu-opioid, delta-opioid, and kappa-opioid receptors. Molecular Brain Research 1994; 27: 37-44.
99. Yasuda K, Raynor K, Kong H, Bredeer CD, Takeda J, Bell GI, Reisine T. Cloning and functional comparison of kappa-opioid and delta-opioid receptors from mouse-brain. Proceedings of the National Academy of Sciences USA 1993; 90: 6736-6740.
100. 2+ pathway in the cardiac kappa-opioid receptor. American Journal of Physiology - Cell Physiology 1998; 43: C82-C87.
101. Zhao J, Pei G, Huang YL, Zhong FM, Ma L. Carboxyl terminus of δ-opioid receptor is required for agonist-receptor phosphorylation. Biochemical and Biophysical Research Communications 1997; 238: 71-76.
102. Zhu X, Wang C, Cheng Z, Wu Y, Zhou D, Pei G. The carboxyl terminus of the mouse δ-opioid receptor is not required for agonist dependent activation. Biochemical and Biophysical Research Communications 1997; 232: 513-516.